Cargando…
Ursodeoxycholic acid use in lactating female patients is associated with clinically negligible concentrations of this bile acid in breast milk
In the literature on the safety of ursodeoxycholic acid (UDCA) during breastfeeding, insufficient data has been reported to date. Thus, the aim of our study was to analyze bile acid (BA) concentrations in breast milk in a cohort of patients, treated with UDCA, and with various cholestatic liver dise...
Autores principales: | Šimják, Patrik, Petr, Tomáš, Kaslová, Barbora, Fejfar, Tomáš, Hůlek, Petr, Pařízek, Antonín, Vítek, Libor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666662/ https://www.ncbi.nlm.nih.gov/pubmed/36379995 http://dx.doi.org/10.1038/s41598-022-24253-y |
Ejemplares similares
-
Author Correction: Ursodeoxycholic acid use in lactating female patients is associated with clinically negligible concentrations of this bile acid in breast milk
por: Šimják, Patrik, et al.
Publicado: (2022) -
Quality Improvement Guidelines for Transjugular Intrahepatic Portosystemic Shunt (TIPS)
por: Krajina, Antonin, et al.
Publicado: (2012) -
Bile acids decrease intracellular bilirubin levels in the cholestatic liver: implications for bile acid-mediated oxidative stress
por: Muchova, Lucie, et al.
Publicado: (2011) -
Overview of Bile Acids Signaling and Perspective on the Signal of Ursodeoxycholic Acid, the Most Hydrophilic Bile Acid, in the Heart
por: Hanafi, Noorul Izzati, et al.
Publicado: (2018) -
Secondary bile acid ursodeoxycholic acid alters weight, the gut microbiota, and the bile acid pool in conventional mice
por: Winston, Jenessa A., et al.
Publicado: (2021)